198 related articles for article (PubMed ID: 30038391)
61. The diagnostic significance of Fourier-domain optical coherence tomography in Sjögren syndrome, aqueous tear deficiency and lipid tear deficiency patients.
Qiu X; Gong L; Lu Y; Jin H; Robitaille M
Acta Ophthalmol; 2012 Aug; 90(5):e359-66. PubMed ID: 22568661
[TBL] [Abstract][Full Text] [Related]
62. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
63. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells.
Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH
Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724
[TBL] [Abstract][Full Text] [Related]
64. Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.
Zhou J; Jin JO; Du J; Yu Q
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7831-8. PubMed ID: 26658504
[TBL] [Abstract][Full Text] [Related]
65. Reduced tear thrombospondin-1/matrix metalloproteinase-9 ratio can aid in detecting Sjögren's syndrome etiology in patients with dry eye.
Masli S; Akpek EK
Clin Transl Sci; 2022 Aug; 15(8):1999-2009. PubMed ID: 35610740
[TBL] [Abstract][Full Text] [Related]
66. Tear levels of IL-7, IL-1α, and IL-1β may differentiate between IgG4-related disease and Sjögren's syndrome.
Martín-Nares E; Hernández-Molina G; Lima G; Hernández-Ramírez DF; Chan-Campos I; Saavedra-González V; Llorente L
Clin Rheumatol; 2023 Apr; 42(4):1101-1105. PubMed ID: 36627528
[TBL] [Abstract][Full Text] [Related]
67. Tear fluid measurement of anti-SS-A and anti-SS-B antibody in anti-SS-A and anti-SS-B seronegative Sjögren's syndrome patients.
Zandbelt M; te Boome L; Klasen I; van de Putte L; van den Hoogen F
Clin Exp Rheumatol; 2009; 27(3):536. PubMed ID: 19604453
[No Abstract] [Full Text] [Related]
68. Early Dry Eye Disease Onset in a NOD.H-2h4 Mouse Model of Sjögren's Syndrome.
Li L; Jasmer KJ; Camden JM; Woods LT; Martin AL; Yang Y; Layton M; Petris MJ; Baker OJ; Weisman GA; Petris CK
Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):18. PubMed ID: 35727180
[TBL] [Abstract][Full Text] [Related]
69. Surface activity of tear fluid in patients with primary Sjögren's syndrome.
Zhao J; Manthorpe R; Wollmer P
Clin Physiol Funct Imaging; 2002 Jan; 22(1):24-7. PubMed ID: 12003095
[TBL] [Abstract][Full Text] [Related]
70. Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren's syndrome versus non-Sjogren's syndrome.
Cubuk MO; Ucgul AY; Ozgur A; Ozulken K; Yuksel E
Int Ophthalmol; 2021 Apr; 41(4):1479-1485. PubMed ID: 33484384
[TBL] [Abstract][Full Text] [Related]
71. Tear proteomic analysis of Sjögren syndrome patients with dry eye syndrome by two-dimensional-nano-liquid chromatography coupled with tandem mass spectrometry.
Li B; Sheng M; Li J; Yan G; Lin A; Li M; Wang W; Chen Y
Sci Rep; 2014 Aug; 4():5772. PubMed ID: 25159733
[TBL] [Abstract][Full Text] [Related]
72. MUC16 expression in Sjogren's syndrome, KCS, and control subjects.
Caffery B; Joyce E; Heynen ML; Jones L; Ritter R; Gamache DA; Senchyna M
Mol Vis; 2008; 14():2547-55. PubMed ID: 19122828
[TBL] [Abstract][Full Text] [Related]
73. Ablation of the Chaperone Protein ERdj5 Results in a Sjögren's Syndrome-Like Phenotype in Mice, Consistent With an Upregulated Unfolded Protein Response in Human Patients.
Apostolou E; Moustardas P; Iwawaki T; Tzioufas AG; Spyrou G
Front Immunol; 2019; 10():506. PubMed ID: 30967862
[No Abstract] [Full Text] [Related]
74. Antibody protein array analysis of the tear film cytokines.
Li S; Sack R; Vijmasi T; Sathe S; Beaton A; Quigley D; Gallup M; McNamara NA
Optom Vis Sci; 2008 Aug; 85(8):653-60. PubMed ID: 18677223
[TBL] [Abstract][Full Text] [Related]
75. Comparison of MicroRNA Expression in Tears of Normal Subjects and Sjögren Syndrome Patients.
Kim YJ; Yeon Y; Lee WJ; Shin YU; Cho H; Sung YK; Kim DR; Lim HW; Kang MH
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4889-4895. PubMed ID: 31752018
[TBL] [Abstract][Full Text] [Related]
76. Berunda Polypeptides: Biheaded Rapamycin Carriers for Subcutaneous Treatment of Autoimmune Dry Eye Disease.
Lee C; Guo H; Klinngam W; Janga SR; Yarber F; Peddi S; Edman MC; Tiwari N; Liu S; Louie SG; Hamm-Alvarez SF; MacKay JA
Mol Pharm; 2019 Jul; 16(7):3024-3039. PubMed ID: 31095909
[TBL] [Abstract][Full Text] [Related]
77. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
[TBL] [Abstract][Full Text] [Related]
78. Lacrimal proteins in Sjögren's syndrome.
Suárez JC
Ophthalmologica; 1987; 194(4):188-90. PubMed ID: 3627703
[TBL] [Abstract][Full Text] [Related]
79. Temperatures of the Ocular Surface, Lid, and Periorbital Regions of Sjögren's, Evaporative, and Aqueous-Deficient Dry Eyes Relative to Normals.
Abreau K; Callan C; Kottaiyan R; Zhang A; Yoon G; Aquavella JV; Zavislan J; Hindman HB
Ocul Surf; 2016 Jan; 14(1):64-73. PubMed ID: 26505667
[TBL] [Abstract][Full Text] [Related]
80. Tear Proteomics Approach to Distinguishing Primary from Secondary Sjögren's Syndrome for Dry Eye Patients with Long-Term Instillation of Eyedrops.
Hsiao YT; Huang YT; Yu HJ; Fang PC; Kuo MT
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
